ÃâÒßѧÊÔÌâ
dS4z Oz"
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
:TG;W,`.V 1. Fas(CD95)/FasL
;p`to"6IFD 2. common chain of cytokine receptor
fe98Y-e 3 . TCR/CD3 complex
,)#rD9ZnC 4. negaive selection of thymocytes
6&ut r!\
7 5. artificial active immune
~$5XiY8A 6. anti-idiotypic
$DIy?kZ 7. IgSF
H~:oW~Ah 8. Integrin
4^l 9d 9. chemokine
L
%is"NZh 10. B7/CD28
[Tp?u8$p` ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
$sda'L5^p 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
xL"J?Gy 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
az0=jou<Zl 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
SYA~I-OYc 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
0lg'QG>
ocZ}RI#Q 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
^]R_t@ µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
s)r!3HS Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
s_IFl5D] 1. B7/CD28
9=MNuV
9/s 2. Th1 subset
PKrG6%
W+ 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
~Dq-q6-@t 4. antibody affinity maturation
-(:T&rfTp 5. AP-1
ue@/o,C> 6. single chain variable fragment£¨ScFv£©
C78g|n{ 7. NK cell receptor
20|_wAA5 8. Zinkernagel-Doherty phenomenon
;QXg*GNAv$ 9. Ig fold
>ceC8"}J5M 10. CD40/CD40L
%u66H2 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
M>
WWP3 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
~iH a^i?2* 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
qr%N/7 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
=M;F&;\8 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
%"mI["{ 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
5WHz_'c
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
{ im?tZ, 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
&!X<F, Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
T"
vf £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
'=E;^'
Rl Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
.>R`#@+I 1.Co-stimulators (or co-stimulating molecules)
$lT8M-yK\ 2.NK-kB
yor'"6)i 3.Immunoglobulin superfamily
P".}Y[GD 4.antigen-presenting cell (APC)
(_e[CqFu 5.death domain
HC$%"peN1b 6.CCR and CXCR
GbQi3% 7.Lectin (or mitogen)
d9S/_iCI 8.Clusters of differentiation, CD)
{FvFah 9.B7 family
<WIIurp 10.Cytotoxic T lymphocyte, CTL)
iuY,E 11.IL-15 and IL-15 receptor (IL-15R)
YgcW1}
12.MHC restriction
`qs,V 13.Affinity-chromatography
wx3_?8z/O 14.Cyctosprin A, CsA
?3BcjD0 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
8S8qj"s ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
>p-UQc 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
vz4(
k/ 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
AA=Ob$2$ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
Qz|T0\=V Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
EX_j|/&tZ ÃâÒßѧרҵ£º
nvrh7l9nX 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
95'+8*YCY Ïû»¯ÄÚ¿Æ£º
.S|7$_9;b 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
A^z{n/DiL ѪҺ²¡Ñ§×¨Òµ£º
ys=}
V| 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
6{.U7=" Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
9 o,`peH (רҵ»ù´¡: ÃâÒßѧ)
{FFdMdxy- Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
X,w X)9]J 1. ADCC(antibody dependent cell-mediated cytotoxicity)
-O$vJ,* 2. »·æß¾úËØ(cyclosporin)
rgIWM" 3. KIR(killer cell inhibitory receptor)
&YY`XEG59O 4. HLDA(human leucocyte differentiation antigen)
:L@;.s 5. Interleukin 18(IL-18)
2ul
8]= 6. ÕûºÏËØ(integrin)
m)L50ot:/ 7. Fas/FasL
q~9-A+n 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
imif[n+]}d 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
/HRKw
D 10. Th1/Th2
]#G s6CsT| 11. »ùÒòÒßÃç(DNAÒßÃç)
6,YoP|@0 12. chemokines and chemokine receptor
\Vx^u}3O 13. ÃâÒßÄÍÊÜ
FcM)v"bF&] 14. ¹²´Ì¼¤·Ö×Ó
eXKEx4rU 15. ËÀÍö½á¹¹Óò(death domain)
b, a7XANsh ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
}=EJM7sM|k 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
mBwz.KEm< 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
LujLC&S £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
zp8x/,gwF £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
c#{
|sR5 £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
GwF8ze+cH £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
q<3La(^/ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
K*5gb^Ul Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
w ?_8OJ ÎÊ´ðÌâ(ÿÌâ25·Ö)
\r:*`Z*y 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
GY?u+|Q 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
?rOj?
J9 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
Zo2+{a 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£